BOZEN, Sud-Tirol, Italy, June 7, 2010 /PRNewswire/ -- Health Robotics announced that its joint-venture Health Robotics Canada Inc. (HRCI), Sandoz Canada Inc., and Sphynx Medical Inc. have all recently signed a marketing agreement to expand into Canada the market presence of i.v.STATION and i.v.SOFT, revolutionary technologies that provide automated sterile compounding of intravenous medications and parenteral nutrition to hospitals.
This new Canadian marketing contract complements HRCI's recently announced multi-faceted strategic agreement with McKesson, guaranteeing the sale, manufacturing, installation, and support of i.v.STATION and i.v.SOFT in Canada and the USA. Today and tomorrow, McKesson will showcase both products at Booth 701 of the American Society of Health-System Pharmacists' Summer Meeting (ASHP) in Tampa, Florida.
Gordon Meyer, Vice President, Hospital Division, Sandoz Canada Inc. stated, As the leader in injectable drugs in Canada, our objective at Sandoz is to facilitate the safe and effective preparation and administration of injectable medications to ensure patient safety. With this marketing collaboration agreement with Sphynx Medical and HRCI, we hope to contribute to the development of business solutions to help our customers cope with some of the most interesting challenges in the hospital pharmacy.
Health Robotics and Sandoz Canada are committed to facilitate smooth integration of Sandoz's market-leading injectable vials with HRCI's products, ensuring that i.v.STATION and i.v.SOFT are optimized for Sandoz's vial formats, vial sizes, vial labels, and specific gravity information, thus reducing the time that Canadian hospitals experience in the installation and implementation of i.v.SOFT and i.v.STATION [showcased last week by NBC News Boston http://www1.whdh.com/video/player/?clipId=4834596].
Everyone at Health Robotics is very proud to collaborate with Sandoz/Novartis, the injectable market leader in Canada. Dynamic and creative, Sandoz Canada has one of the highest growth rates among the largest manufacturers of generic injectable pharmaceutical products in Canada, stated Werner Rainer, Health Robotics' CEO.
Denis Nadeau, President of Sphynx Medical Inc., concluded: I foresee that the introduction of i.v.STATION and i.v.SOFT will dramatically improve the process of I.V. sterile preparations at Canadian hospitals, deriving at least similar clinical and financial benefits that I witnessed in Canada when I led the market introduction at M.E.D.S. of the first automated oral compounding devices in our country 20 years ago.
About Sandoz Canada Inc.
With more than 209 molecules, Sandoz Canada offers one of the broadest portfolios of generic products in Canada. Through product development and innovation, Sandoz demonstrates its leadership by constantly adding to its existing portfolio. Sandoz develops, produces, markets and distributes a wide array of oral, topical, rectal, ophthalmic, and injectable generic products in different formulations (suspension, solution, tablet, capsule, cream, ointment, suppository, gelcap, transdermal patches) and various presentations (ampoules, vials, bottles, mini bags). Through its ability to rise to the numerous challenges inherent to the development of sterile generic products, Sandoz Canada's Development Centre has built a reputation for excellence within the Novartis group. Sandoz Canada employs about 800 people, mostly based at its Boucherville facilities (South Shore of Montreal). For more information, please visit http://www.sandoz.ca/site/en/index.shtml
About Sphynx Medical:
Founded in 1995, and located in Longueuil, Quebec, Sphynx Medical's main focus is the importation and distribution of various innovative and high-tech medical products such as Quidel Corporation's line of rapid detection tests and Med-Logics's calibrated LASIK blades for laser surgeries. For more information, please visit http://sphynxrobot.com/
About Health Robotics:
Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding, powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff. For more information, please visit http://www.health-robotics.com
For additional information, please contact: Health Robotics S.r.l. Claudia Flaim, Marketing Coordinator +39-0471-200-372 flaim@health-robotics.com
SOURCE: Health Robotics
CONTACT: For additional information, please contact: Health RoboticsS.r.l., Claudia Flaim, Marketing Coordinator, +39-0471-200-372,flaim@health-robotics.com
Comments